A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration

Summary

Hereditary angioedema ("HAE") is a disease characterized by recurrent tissue swelling affecting various body locations. Recent literature shows that patients with frequent attacks may benefit from long-term prophylaxis. This study aims to evaluate the safety and prophylactic effect of weekly administrations of 50 IU/kg recombinant C1 Inhibitor ("rhC1INH").

Timeline

Start

2009-06

Primary completion

2010-03

Completion

2010-04

Drugs

Indications